Position in GRAL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,697,962
-$166,298 QoQ
Shares Held
39,519
-28.7% QoQ
Ownership
0.088%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#71
of 374 holders
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Rafferty Asset Management, LLC holds $85,587,160 across 17 Diagnostics & Research names. GRAL ranks #9 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
40,905 | $20,508,130 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
34,084 | $17,943,180 | |
| 3 | DHR |
Danaher Corp /De/
|
69,337 | $13,207,311 | |
| 4 | A |
Agilent Technologies, Inc.
|
31,106 | $4,131,809 | |
| 5 | WAT |
Waters Corp /De/
|
10,809 | $4,053,807 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
18,371 | $3,549,644 | |
| 7 | NTRA |
Natera, Inc.
|
12,749 | $3,460,716 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
2,223 | $2,839,904 |
All Filings in GRAL
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,697,962 | 39,519 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,864,260 | 55,423 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,245,297 | 61,284 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,543,122 | 43,009 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,109,865 | 41,032 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,555,156 | 60,891 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $997,939 | 55,907 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $293,152 | 19,073 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||